By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Manzo Pharmaceuticals, Inc. (MNZO)

OTC Currency in USD
$0.00
$0.00
0.00%
Last Update: 2 Jul 2025, 20:00
$109.95K
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$0.00 - $0.00
52 Week Range

MNZO Stock Price Chart

Explore Manzo Pharmaceuticals, Inc. interactive price chart. Choose custom timeframes to analyze MNZO price movements and trends.

There is nothing to show.

MNZO Company Profile

Discover essential business fundamentals and corporate details for Manzo Pharmaceuticals, Inc. (MNZO) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Shell Companies

IPO Date

31 Dec 1998

Employees

12.00

CEO

Kenneth Manzo

Description

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.

MNZO Financial Timeline

Browse a chronological timeline of Manzo Pharmaceuticals, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

MNZO Stock Performance

Access detailed MNZO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
MNZO
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
MNZO
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More